CBD, marijuana’s famously calming cannabinoid, has played an important role in the recognition of cannabis as a legitimate medicine in the scientific world. And although it’s still early to make assumptions, the current evidence for its efficacy is very promising, especially against seizures and anxiety.
However, as the cannabis industry is waiting to see how the passing of the 2018 Farm Bill will influence research on CBD, a new cannabinoid has been making headlines. Cannabinol, or CBN for short: a cannabis compound that promises to be the next big thing in the industry. But how does it compare with CBD?